A Yajima
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 5
- Obstetrics and Gynecology top 1%
- Pregnancy and preeclampsia studies 12
- Endometrial and Cervical Cancer Treatments 10
- Dermatology top 2%
- Genetics top 5%
- Infectious Diseases top 5%
- Parvovirus B19 Infection Studies 5
-
- Reproductive System and Pregnancy 8
-
- Cervical Cancer and HPV Research 8
-
- Reproductive Biology and Fertility 6
-
- Prenatal Screening and Diagnostics 6
A Yajima
69 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 87
- Reproductive Medicine 465
- Obstetrics and Gynecology 399
- Dermatology 199
- Genetics 419
- Infectious Diseases 246
Countries citing papers authored by A Yajima
This map shows the geographic impact of A Yajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Yajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Yajima more than expected).
Fields of papers citing papers by A Yajima
This network shows the impact of papers produced by A Yajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Yajima. The network helps show where A Yajima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A Yajima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 7 | |
| 2 | 2000 | 52 | |
| 3 | 1999 | 37 | |
| 4 | 1999 | 34 | |
| 5 | 1999 | 36 | |
| 6 | 1999 | 47 | |
| 7 | 1998 | 113 | |
| 8 | 1998 | 73 | |
| 9 | 1997 | 57 | |
| 10 | 1996 | 33 | |
| 11 | 1996 | 50 | |
| 12 | 1996 | 25 | |
| 13 | 1994 | 19 | |
| 14 | 1994 | 8 | |
| 15 | 1993 | 1 | |
| 16 | 1993 | 6 | |
| 17 | Maternal and umbilical venous levels of endothelin in women with pre-eclampsia. | 1992 | 14 |
| 18 | 1991 | 11 | |
| 19 | 1991 | 2 | |
| 20 | 1989 | 47 |
About A Yajima
A Yajima is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Pediatrics, Perinatology and Child Health, Immunology and Developmental Biology, having authored 71 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pregnancy and preeclampsia studies (12 papers), Endometrial and Cervical Cancer Treatments (10 papers), Reproductive System and Pregnancy (8 papers), Cervical Cancer and HPV Research (8 papers), Reproductive Biology and Fertility (6 papers), Prenatal Screening and Diagnostics (6 papers), Parvovirus B19 Infection Studies (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). The work is most often cited by research in Reproductive Medicine (465 citations), Obstetrics and Gynecology (399 citations), Dermatology (199 citations), Genetics (419 citations) and Infectious Diseases (246 citations). A Yajima has collaborated with scholars based in Japan, Australia and United Kingdom. Frequent co-authors include Hironobu Sasano, Tomohiro Fukaya, Takashi Suzuki, R. Takaya, Shinji Sato, Nobuo Yaegashi, H Nagura, Kazuo Sugamura, Masataka Nakamura and M Tamura. Their work appears in journals such as Gynecologic and Obstetric Investigation, Human Reproduction, British Journal of Cancer, The Journal of Clinical Endocrinology & Metabolism and Clinical Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.